Skip to content

Effect of TECAR therapy on the improvement of symptoms and function of patients with lateral epicondylitis

Evaluation of TECAR therapy on the improvement of symptoms and function of patients with lateral epicondylitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220115053718N1
Enrollment
46
Registered
2022-01-21
Start date
2022-01-21
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral epicondylitis. Medial epicondylitis

Interventions

Intervention 1: Intervention group: Patients in this group undergo TECAR therapy for 5 sessions, 3 days a week (every other day for 2 weeks). In addition, meloxicam 15 mg is prescribed for two weeks.

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of lateral epicondylitis by a physical medicine and rehabilitation specialist with physical examination Lateral epicondylitis pain that lasts for at least 1 month Age category 18-65 years Satisfaction to participate in the study

Exclusion criteria

Exclusion criteria: Having history of inflammatory joint disease Having history of affected elbow surgery, injection or physiotherapy of the affected elbow in the last 6 months Having history of trauma and elbow injury Existence of diseases that mimic the symptoms of lateral epicondylitis Contraindications to pregnancy (pregnancy, pacemaker, insulin pump, hearing aid, thrombophlebitis, growth plate, cancer, open wounds and skin lesions, skin allergies, fever and infection, lack of heat and heart disease)

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before treatment, immediately and 1 month after the end of treatment. Method of measurement: Visual Analogue Scale(VAS).;The Disabilities of arm, shoulder and hand Score. Timepoint: Before treatment, immediately and 1 month after the end of treatment. Method of measurement: The Disabilities of the Arm, Shoulder and Hand questionnaire(DASH).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Taheri

Esfahan University of Medical Sciences

Prs_taheri@yahoo.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026